DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

50.14 0.77 (1.56%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $50.14 1.56%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.79
Previous Close $49.37
Daily Range $48.35 - $50.15
52-Week Range $45.69 - $63.62
Market Cap $141.2B
P/E Ratio 14.56
Dividend (Yield) $1.80 (3.6%)
Ex-Dividend Date
Dividend Pay Date
Volume 24,269,314
Average Daily Volume 15,617,935
Current FY EPS $3.50




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

Inovio Pharmaceuticals' Potentially Hollow Victory Buys it More Time

Inovio lands a substantial government contract to continue its Ebola vaccine research, but don't go popping open the champagne just yet.

5 Big FDA Decisions Expected in October

FDA approves Merck's Keytruda for use in lung cancer

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

3 Stocks Underperforming Today In The Drugs Industry

Are These 5 Popular Dividend Stocks Truly Cheap?

Charles Brandes' Most Weighted Trades in Q2 2015

iShares U.S. Pharmaceuticals ETF Experiences Big Outflow

3 Reasons Pfizer Is the Strongest Big Pharma Play Now

Did Eli Lilly Just Get a Leg Up on Johnson & Johnson?

Armed with a unique profile, Jardiance could finally dent Invokana's leading share in the next-gen type 2 diabetes market.

See More MRK News...

MRK's Top Competitors

MRK $50.14 (1.56%)
Current stock: MRK
JNJ $93.93 (0.82%)
Current stock: JNJ
NVS $93.27 (1.49%)
Current stock: NVS
RHHBY $33.32 (0.32%)
Current stock: RHHBY